Methodological quality assessment of clinical guidelines and consensus for lupus nephritis_Chinese Journal of Evidence-Based Medicine

Authors：

 ZENG Rong ¹ , LI Ruizhe ² , FU Yiwen ² , HAN Wanruo ² , FENG Xiaowen ²

1. Department of Nephrology, the Second Hospital of Lanzhou University, Lanzhou 730000, P.R.China;
2. The Second Clinical Medical College of Lanzhou University, Lanzhou 730000, P.R.China;

Corresponding?author：

ZENG Rong, Email: zengrong05@126.com

Keywords：

Lupus nephritis; Clinical practice guideline; AGREE Ⅱ; Quality assessment

DOI：

10.7507/1672-2531.202108144

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Objective To assess the methodological quality of clinical guidelines and consensus of lupus nephritis, to collect the recommendations of each guideline, and to provide references for clinical decision-making. Methods PubMed, CNKI, and CBM databases and related websites such as NGC, NICE, GIN, SIGN, and Medive were electronically searched from January 2012 to December 2020 to collect the clinical guidelines and expert consensus for lupus nephritis. After consistency evaluation by four evaluators, the methodological quality of the included guidelines or expert consensus was evaluated using AGREE Ⅱ. The relevant recommendations, evidence level, and recommended strength of each guideline in treating lupus nephritis were summarized. Results A total of eight guidelines and two consensus statements were included. Among them, eight guidelines or consensus statements were level B (generally recommended guidelines), and two were level C (non-recommended guidelines). Relevant recommendations mainly gave the corresponding treatment scheme according to the pathological type of lupus nephritis. Conclusion The methodological quality of lupus nephritis guideline formulation in China needs to be improved. The included guidelines and consensus can provide reference for clinical decision-makers. However, higher-quality clinical practice guidelines for the Chinese population are needed to be developed in the future.

Citation： ZENG Rong, LI Ruizhe, FU Yiwen, HAN Wanruo, FENG Xiaowen. Methodological quality assessment of clinical guidelines and consensus for lupus nephritis. Chinese Journal of Evidence-Based Medicine, 2022, 22(1): 103-110. doi: 10.7507/1672-2531.202108144 Copy

1.	Wang Z, Wang Y, Zhu R, et al. Long-term survival and death causes of systemic lupus erythematosus in China: a systemic review of observational studies. Medicine (Baltimore), 2015, 94(17): e794.
2.	Lee YH, Choi SJ, Ji JD, et al. Overall and cause-specific mortality in systemic lupus erythematosus: an updated meta-analysis. Lupus, 2016, 25(7): 727-734.
3.	Yap DY, Chan TM. Lupus nephritis in Asia: clinical features and management. Kidney Dis (Basel), 2015, 1(2): 100-109.
4.	Bertsias GK, Tektonidou M, Amoura Z, et al. Joint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis. Ann Rheum Dis, 2012, 71(11): 1771-1782.
5.	Fanouriakis A, Kostopoulou M, Cheema K, et al. 2019 Update of the Joint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of lupus nephritis. Ann Rheum Dis, 2020, 79(6): 713-723.
6.	中國狼瘡腎炎診斷和治療指南編寫組. 中國狼瘡腎炎診斷和治療指南. 中華醫學雜志, 2019, (44): 3441-3455.
7.	AGREE Enterprise. AGREE Ⅱ instrument, 2017. Available at: https://www.agreetrust.org/.
8.	Krook JE, O'Connell MJ, Wieand HS, et al. A prospective, randomized evaluation of intensive-course 5-fluorouracil plus doxorubicin as surgical adjuvant chemotherapy for resected gastric cancer. Cancer, 1991, 67(10): 2454-2458.
9.	Groot N, de Graeff N, Marks SD, et al. European evidence-based recommendations for the diagnosis and treatment of childhood-onset lupus nephritis: the SHARE initiative. Ann Rheum Dis, 2017, 76(12): 1965-1973.
10.	Hahn BH, McMahon MA, Wilkinson A, et al. American College of Rheumatology guidelines for screening, treatment, and management of lupus nephritis. Arthritis Care Res (Hoboken), 2012, 64(6): 797-808.
11.	Klumb EM, Silva CA, Lanna CC, et al. Consensus of the Brazilian Society of Rheumatology for the diagnosis, management and treatment of lupus nephritis. Rev Bras Reumatol, 2015, 55(1): 1-21.
12.	Mina R, von Scheven E, Ardoin SP, et al. Consensus treatment plans for induction therapy of newly diagnosed proliferative lupus nephritis in juvenile systemic lupus erythematosus. Arthritis Care Res (Hoboken), 2012, 64(3): 375-383.
13.	van Tellingen A, Voskuyl AE, Vervloet MG, et al. Dutch guidelines for diagnosis and therapy of proliferative lupus nephritis. Neth J Med, 2012, 70(4): 199-207.
14.	Pons-Estel BA, Bonfa E, Soriano ER, et al. First Latin American clinical practice guidelines for the treatment of systemic lupus erythematosus: Latin American Group for the Study of Lupus (GLADEL, Grupo Latino Americano de Estudio del Lupus)-Pan-American League of Associations of Rheumatology (PANLAR). Ann Rheum Dis, 2018, 77(11): 1549-1557.
15.	Bramham K, Soh MC, Nelson-Piercy C. Pregnancy and renal outcomes in lupus nephritis: an update and guide to management. Lupus, 2012, 21(12): 1271-1283.
16.	黨西強, 易著文. 狼瘡性腎炎診治循證指南(2016)解讀. 中華兒科雜志, 2018, 56(2): 95-99.
17.	單帥帥, 王慶偉, 文建國. 臨床指南和專家共識的基本概念與制定規范. 中華小兒外科雜志, 2020, 41(2): 107-111.
18.	楊學寧, 吳一龍. 臨床證據水平分級和推薦級別. 循證醫學, 2003, 3(2): 111-113.
19.	Tanaka H, Oki E, Tsuruga K, et al. Management of young patients with lupus nephritis using tacrolimus administered as a single daily dose. Clin Nephrol, 2009, 72(6): 430-436.
20.	Trachana M, Koutsonikoli A, Farmaki E, et al. Safety and efficacy of rituximab in refractory pediatric systemic lupus erythematosus nephritis: a single-center experience of Northern Greece. Rheumatol Int, 2013, 33(3): 809-813.
21.	Ruggiero B, Vivarelli M, Gianviti A, et al. Lupus nephritis in children and adolescents: results of the Italian Collaborative Study. Nephrol Dial Transplant, 2013, 28(6): 1487-1496.
22.	劉正釗, 胡偉新, 章海濤, 等. 激素聯合雷公藤多苷治療V型狼瘡性腎炎的臨床療效. 腎臟病與透析腎移植雜志, 2008, 17(6): 512-516.

1. Wang Z, Wang Y, Zhu R, et al. Long-term survival and death causes of systemic lupus erythematosus in China: a systemic review of observational studies. Medicine (Baltimore), 2015, 94(17): e794.
2. Lee YH, Choi SJ, Ji JD, et al. Overall and cause-specific mortality in systemic lupus erythematosus: an updated meta-analysis. Lupus, 2016, 25(7): 727-734.
3. Yap DY, Chan TM. Lupus nephritis in Asia: clinical features and management. Kidney Dis (Basel), 2015, 1(2): 100-109.
4. Bertsias GK, Tektonidou M, Amoura Z, et al. Joint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis. Ann Rheum Dis, 2012, 71(11): 1771-1782.
5. Fanouriakis A, Kostopoulou M, Cheema K, et al. 2019 Update of the Joint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of lupus nephritis. Ann Rheum Dis, 2020, 79(6): 713-723.
6. 中國狼瘡腎炎診斷和治療指南編寫組. 中國狼瘡腎炎診斷和治療指南. 中華醫學雜志, 2019, (44): 3441-3455.
7. AGREE Enterprise. AGREE Ⅱ instrument, 2017. Available at: https://www.agreetrust.org/.
8. Krook JE, O'Connell MJ, Wieand HS, et al. A prospective, randomized evaluation of intensive-course 5-fluorouracil plus doxorubicin as surgical adjuvant chemotherapy for resected gastric cancer. Cancer, 1991, 67(10): 2454-2458.
9. Groot N, de Graeff N, Marks SD, et al. European evidence-based recommendations for the diagnosis and treatment of childhood-onset lupus nephritis: the SHARE initiative. Ann Rheum Dis, 2017, 76(12): 1965-1973.
10. Hahn BH, McMahon MA, Wilkinson A, et al. American College of Rheumatology guidelines for screening, treatment, and management of lupus nephritis. Arthritis Care Res (Hoboken), 2012, 64(6): 797-808.
11. Klumb EM, Silva CA, Lanna CC, et al. Consensus of the Brazilian Society of Rheumatology for the diagnosis, management and treatment of lupus nephritis. Rev Bras Reumatol, 2015, 55(1): 1-21.
12. Mina R, von Scheven E, Ardoin SP, et al. Consensus treatment plans for induction therapy of newly diagnosed proliferative lupus nephritis in juvenile systemic lupus erythematosus. Arthritis Care Res (Hoboken), 2012, 64(3): 375-383.
13. van Tellingen A, Voskuyl AE, Vervloet MG, et al. Dutch guidelines for diagnosis and therapy of proliferative lupus nephritis. Neth J Med, 2012, 70(4): 199-207.
14. Pons-Estel BA, Bonfa E, Soriano ER, et al. First Latin American clinical practice guidelines for the treatment of systemic lupus erythematosus: Latin American Group for the Study of Lupus (GLADEL, Grupo Latino Americano de Estudio del Lupus)-Pan-American League of Associations of Rheumatology (PANLAR). Ann Rheum Dis, 2018, 77(11): 1549-1557.
15. Bramham K, Soh MC, Nelson-Piercy C. Pregnancy and renal outcomes in lupus nephritis: an update and guide to management. Lupus, 2012, 21(12): 1271-1283.
16. 黨西強, 易著文. 狼瘡性腎炎診治循證指南(2016)解讀. 中華兒科雜志, 2018, 56(2): 95-99.
17. 單帥帥, 王慶偉, 文建國. 臨床指南和專家共識的基本概念與制定規范. 中華小兒外科雜志, 2020, 41(2): 107-111.
18. 楊學寧, 吳一龍. 臨床證據水平分級和推薦級別. 循證醫學, 2003, 3(2): 111-113.
19. Tanaka H, Oki E, Tsuruga K, et al. Management of young patients with lupus nephritis using tacrolimus administered as a single daily dose. Clin Nephrol, 2009, 72(6): 430-436.
20. Trachana M, Koutsonikoli A, Farmaki E, et al. Safety and efficacy of rituximab in refractory pediatric systemic lupus erythematosus nephritis: a single-center experience of Northern Greece. Rheumatol Int, 2013, 33(3): 809-813.
21. Ruggiero B, Vivarelli M, Gianviti A, et al. Lupus nephritis in children and adolescents: results of the Italian Collaborative Study. Nephrol Dial Transplant, 2013, 28(6): 1487-1496.
22. 劉正釗, 胡偉新, 章海濤, 等. 激素聯合雷公藤多苷治療V型狼瘡性腎炎的臨床療效. 腎臟病與透析腎移植雜志, 2008, 17(6): 512-516.

Previous Article
Yearly-end thanks and prospects
Next Article
Development and validation for evaluation of an evaluation tool for guideline implementation

Chinese Journal of Evidence-Based Medicine

Methodological quality assessment of clinical guidelines and consensus for lupus nephritis

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Next Article

Format

Content